首页> 外文OA文献 >Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways
【2h】

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways

机译:豚鼠和人呼吸道中格隆溴铵与噻托铵和异丙托铵的作用持续时间的药理学评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our study was aimed at investigating the duration of the bronchodilator action of the antimuscarinc drug glycopyrrolate compared to tiotropium and ipratropium.In the guinea-pig isolated trachea, the time (t1/2) necessary for a contractile response to carbachol (0.3 μM) to return to 50% recovery after washout of the antagonist was studied. The offset of the antagonist effect of glycopyrrolate, tiotropium and ipratropium (10 nM each) was t1/2=4.0±0.5, >4.5 and 0.5±0.1 h, respectively. At 4.5 h from the washout of the antagonist, the recovery of the response to carbachol was 50±8, 10±4 and 70±7%, respectively.In the human isolated bronchus, the offset of the bronchodilator effects of glycopyrrolate (3 nM), tiotropium (1 nM) and ipratropium (10 nM) was t1/2=3.7±0.2; >6 and 3.0±0.2 h, respectively. At 6.0 h from the washout of the antagonist, the recovery of the response to carbachol (1 μM) was 101±10, 27±3 and 110±10%, respectively.In anaesthetized guinea-pigs, acetylcholine-induced bronchoconstriction was markedly reduced by intratracheal instillation of glycopyrrolate (3 nmol kg−1; 88.1±4% inhibition), tiotropium (1.3 nmol kg−1; 86.2±5% inhibition) or ipratropium (1.45 nmol kg−1; 88.1±10% inhibition). These inhibitory effects assessed 3 or 24 h after antagonist administration were reduced to 69.9±5 and 29.7±6%; 28.3±5 and 14.2±5% for glycopyrrolate and ipratropium, respectively, whereas they remained stable (83.5±4; 70.6±6) for tiotropium. The residual inhibitory effect of glycopyrrolate was also assessed at 16 h from administration, and proved to be as low as that found at 24 h (31.2±10 vs 29.7±6%, respectively).In conclusion, glycopyrrolate-induced bronchodilation has a longer duration than that of ipratropium, but less than that of tiotropium. The efficacy of a possible glycopyrrolate-based therapy for asthma or chronic obstructive pulmonary disease given once-a-day is not guaranteed by the present investigation.
机译:我们的研究旨在研究抗毒蕈碱药物格隆溴铵与噻托溴铵和异丙托溴铵相比,支气管扩张药作用的持续时间。在豚鼠分离的气管中,对卡巴胆碱(0.3μm)收缩反应所需的时间(t1 / 2)研究了清除拮抗剂后恢复到50%的回收率。格隆溴铵,噻托溴铵和异丙托溴铵(各10 nM)的拮抗作用抵消分别为t1 / 2 = 4.0±0.5,> 4.5和0.5±0.1±h。从拮抗剂清除后的4.5 h,对卡巴胆碱的响应恢复分别为50±8、10±4和70±7%。在人分离的支气管中,格隆溴铵(3(nM ),噻托溴铵(1 nM)和异丙托溴铵(10 nM)为t1 / 2 = 3.7±0.2; > 6和3.0±0.2 h。在从拮抗剂洗脱出来的6.0 h处,对卡巴胆碱(1μM)的响应恢复分别为101±10%,27±3%和110±10%。在麻醉的豚鼠中,乙酰胆碱引起的支气管收缩明显减少。气管内滴注格隆溴铵(3 nmol kg-1;抑制率88.1±4%),噻托溴铵(1.3 nmol kg-1;抑制率86.2±5%)或异丙托溴铵(1.45 nmol kg-1;抑制率88.1±10%)。拮抗剂给药后3或24 h评估的这些抑制作用降低至69.9±5和29.7±6%。格隆溴铵和异丙托铵分别为28.3±5和14.2±5%,而噻托溴铵则保持稳定(83.5±4; 70.6±6)。在给药后16 h还评估了格隆溴铵的残留抑制作用,事实证明其与24 h时一样低(分别为31.2±10比29.7±6%)。持续时间比异丙托铵的持续时间短,但比噻托溴铵的持续时间短。本研究不能保证每天给予一次可能的基于格隆溴铵的疗法对哮喘或慢性阻塞性肺疾病的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号